DIA DEEP DIVE: Diversity and Inclusion

Donate Now Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

A recent study finds little racial diversity in cancer drug clinical trials, raising concerns about how genetic differences may affect the effectiveness of new cancer drugs.

Want to dig deeper into diversity and inclusion?

Article

Advancing Clinical Trial Diversity Through Community Engagement
Richardae Araojo et al.
Global Forum
Read Now
Podcast

How Do You Put Your Disease on the Agenda?
Jennifer Brea
Listen Now
Article

Innovation and Opportunities in Pediatric Therapeutic Development
Susan McCune et al.
Therapeutic Innovation & Regulatory Science
Member-only content
Read Now
Article

Tiny and Forgotten: A Call for Focused Neonatal Policy Reform
Christina M. Bucci-Rechtweg et al.
Therapeutic Innovation & Regulatory Science
Member-only content
Read Now
Article

Clinical Trial Diversity: Moving from Admiring the Problem to Solving It
Richardae Araojo et al.
Global Forum
Read Now

Want to learn more about diversity and inclusion?

To facilitate more inclusive clinical research and development, plan to attend Advancing Complex Innovative Clinical Trial Designs to Efficiently Deliver Medicines to Patients or our Digital Technology in Clinical Trials conference.

Related Perspectives

Guidance

From FDA: Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry
Read Now
Article

From WAMU: Children Of Color’s Health Can Be Affected By Racism. Here’s What Doctors Can Do To Help.
Read Now
Article

From MedCityNews: As precision medicine grows, so does the importance of clinical trial diversity
Read Now